Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Vicarious Surgical Inc. (RBOT)

NYSE - Nasdaq Real Time Price. Currency in USD
2.9500-0.0600 (-1.99%)
At close: 04:00PM EST
2.8800 -0.07 (-2.37%)
After hours: 07:20PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.0100
Open2.9300
Bid0.0000 x 1200
Ask0.0000 x 800
Day's Range2.8900 - 3.1700
52 Week Range1.6900 - 6.6300
Volume365,314
Avg. Volume481,513
Market Cap360.992M
Beta (5Y Monthly)0.75
PE Ratio (TTM)N/A
EPS (TTM)-5.1610
Earnings DateAug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.75
  • Business Wire

    Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023

    WALTHAM, Mass., January 30, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after the market closes on Monday, February 13, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

  • Business Wire

    Vicarious Surgical Announces Changes to Board of Directors

    WALTHAM, Mass., January 23, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the appointment of Victoria Carr-Brendel, Ph.D. to the Vicarious Surgical Board of Directors effective today, January 23, 2023. The Company also announced the resignation of technology-focused venture capitalist Phil Liang from the Vicarious Surgical Board of Directors ef

  • Business Wire

    Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System

    WALTHAM, Mass., December 22, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, hosted the first public demonstration of its Beta 2 surgical robotic platform on December 6, 2022, highlighting the latest evolution of its differentiated technology and showcasing recent cadaveric testing. Supporting presentations by representatives from leading healthcare provider Uni

Advertisement
Advertisement